These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 31944066)

  • 1. Identifying Tardive Dyskinesia: Risk Factors, Functional Impact, and Diagnostic Tools.
    Saklad SR
    J Clin Psychiatry; 2020 Jan; 81(1):. PubMed ID: 31944066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Revisiting Tardive Dyskinesia: Focusing on the Basics of Identification and Treatment.
    Citrome L; Saklad SR
    J Clin Psychiatry; 2020 Feb; 81(2):. PubMed ID: 32078259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Earlier Diagnosis of Tardive Dyskinesia.
    Kremens DE
    J Clin Psychiatry; 2019 Dec; 81(1):. PubMed ID: 31846242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prevention and treatment of tardive dyskinesia caused by antipsychotic drugs].
    Seigneurie AS; Sauvanaud F; Limosin F
    Encephale; 2016 Jun; 42(3):248-54. PubMed ID: 26922134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implications of Antipsychotic Use: Antipsychotic-Induced Movement Disorders, with a Focus on Tardive Dyskinesia.
    Dilks S; Xavier RM; Kelly C; Johnson J
    Nurs Clin North Am; 2019 Dec; 54(4):595-608. PubMed ID: 31703784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychosocial Implications of Tardive Dyskinesia in Patients With Mood Disorders Versus Schizophrenia.
    McEvoy JP
    J Clin Psychiatry; 2019 Dec; 80(6):. PubMed ID: 31846247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical management of tardive dyskinesia: Five steps to success.
    Citrome L
    J Neurol Sci; 2017 Dec; 383():199-204. PubMed ID: 29246613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiology, Prevention, and Assessment of Tardive Dyskinesia and Advances in Treatment.
    Correll CU; Kane JM; Citrome LL
    J Clin Psychiatry; 2017; 78(8):1136-1147. PubMed ID: 29022654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment Strategies for Tardive Dyskinesia.
    Kremens DE
    J Clin Psychiatry; 2019 Dec; 81(1):. PubMed ID: 31880872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of Tardive Dyskinesia: A General Overview with Focus on the Vesicular Monoamine Transporter 2 Inhibitors.
    Niemann N; Jankovic J
    Drugs; 2018 Apr; 78(5):525-541. PubMed ID: 29484607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tardive Dyskinesia: Recognition, Patient Assessment, and Differential Diagnosis.
    Jain R; Correll CU
    J Clin Psychiatry; 2018; 79(2):. PubMed ID: 29570969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tardive dyskinesia: Out of the shadows.
    Hauser RA; Truong D
    J Neurol Sci; 2018 Jun; 389():1-3. PubMed ID: 29449008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differentiating tardive dyskinesia: a video-based review of antipsychotic-induced movement disorders in clinical practice.
    Hauser RA; Meyer JM; Factor SA; Comella CL; Tanner CM; Xavier RM; Caroff SN; Lundt L
    CNS Spectr; 2022 Apr; 27(2):208-217. PubMed ID: 33213556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlates of the Abnormal Involuntary Movement Scale in Veterans With Tardive Dyskinesia.
    Caroff SN; Leong SH; Roberts CB; Berkowitz RM; Campbell EC
    J Clin Psychopharmacol; 2020; 40(4):373-380. PubMed ID: 32639290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antipsychotic-induced tardive syndromes].
    Fleischhacker WW; Hofer A; Jagsch C; Pirker W; Psota G; Rittmannsberger H; Seppi K
    Neuropsychiatr; 2016 Sep; 30(3):123-130. PubMed ID: 27580887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cumulative Burden of Illness in Veterans With Tardive Dyskinesia and Serious Mental Disorders.
    Caroff SN; Leong SH; Roberts C; Berkowitz RM; Campbell EC
    J Clin Psychopharmacol; 2020; 40(1):38-45. PubMed ID: 31834084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tardive Syndromes.
    Friedman JH
    Continuum (Minneap Minn); 2019 Aug; 25(4):1081-1098. PubMed ID: 31356294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Valbenazine for the treatment of tardive dyskinesia.
    Seeberger LC; Hauser RA
    Expert Opin Pharmacother; 2017 Aug; 18(12):1279-1287. PubMed ID: 28699794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. KINECT 3: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Trial of Valbenazine for Tardive Dyskinesia.
    Hauser RA; Factor SA; Marder SR; Knesevich MA; Ramirez PM; Jimenez R; Burke J; Liang GS; O'Brien CF
    Am J Psychiatry; 2017 May; 174(5):476-484. PubMed ID: 28320223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of Tardive Dyskinesia.
    Bashir HH; Jankovic J
    Neurol Clin; 2020 May; 38(2):379-396. PubMed ID: 32279716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.